跳至主要内容
临床试验/NCT01442207
NCT01442207撤回3 期

Cerclage Placement for the Prevention of Preterm Birth in Women With Placenta Previa - A Multicenter Randomized Controlled Trial

Obstetrix Medical Group0 个研究点开始时间: 2012年3月1日最近更新:
适应症

试验速览

阶段
3 期
状态
撤回
发起方
主要终点
Gestational age (GA) at birth

研究概览

简要总结

The purpose of the study is to compare the role of cervical cerclage versus expectant management in women with complete placenta previa (≥ 10mm over internal os) presenting with shortened cervical length ( ≥ 10mm and ≤ 30mm) between 18w0d and 26w0d of pregnancy.

详细描述

The purpose of this study is to perform a large multi-center randomized trial comparing the role of cervical cerclage versus expectant management in women with placenta previa presenting with shortened cervical length ( ≥ 10mm and ≤ 30mm) between 18w0d and 26w0d of gestation. In addition, the role of fetal fibronectin (fFN) for the prediction of preterm birth and hemorrhage will be elucidated. The hypothesis is that placement of a cervical cerclage between 18w0d to 26w0d in patients with a short cervix and complete placenta previa will decrease preterm birth as compared to expectantly managing these patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Singleton pregnancy, ≥ 18yrs old
  • GA 18w0d to 26w0d inclusive @ time of enrollment
  • Documentation of complete placenta previa (≥ 10mm over internal os)
  • Agrees to participate in trial and signs/date an informed consent form.

排除标准

  • Contraindication to expectant management (i.e. active labor, Non-reassuring fetal heart rate (NRFHR), Intrauterine fetal demise (IUFD), uncontrolled hemorrhage)
  • Fetal condition likely to cause serious neonatal morbidity independent of GA (e.g. hydrops, fetal viral infections, fetal malformations likely to need surgery like hydrocephalus, neural tube defects, cardiac defects, abdominal wall defects)
  • Known uterine anomaly at time of enrollment
  • History of two or more prior cesarean deliveries
  • Suspected placenta accrete, increta or percreta on US at enrollment
  • Cervical cerclage present at time of enrollment

结局指标

主要结局

Gestational age (GA) at birth

时间窗: measure taken in the first 23 hours after birth.

The gestational age (GA) of the baby noted at birth

次要结局

  • Newborn Birth weight(measured within 1-2 days after birth)
  • Need for Maternal Blood Product replacement(measured from the time participant is enrolled in the study until 30 days after delivery.(approximately 40 weeks))
  • Number of participants delivering prematurely following hemorrhage who have a positive fFN test.(measured at delivery)

研究者

发起方
Obstetrix Medical Group
申办方类型
Industry
责任方
Sponsor

相似试验